Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$318.10M
Total Bought:
$49.56M
Total Sold:
$48.18M
Net Transaction:
+$1.38M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Entrada Therapeutics, Inc.(TRDA)4,256,3794,056,379-200,000$24.69M$41.70M13.11%+$17.01M
CAMP4 THERAPEUTICS CORPORATION(CAMP)5,869,0915,869,0910$17.61M$35.98M11.31%+$18.37M
Tyra Biosciences, Inc.(TYRA)939,2981,029,298+90,000$13.14M$27.06M8.51%+$13.92M
Viridian Therapeutics, Inc.(VRDN)736,595736,5950$15.90M$22.92M7.21%+$7.03M
Pharvaris N V
COM
797,600797,6000$19.90M$22.13M6.96%+$2.23M
Erasca, Inc.(ERAS)5,405,4045,405,4040$11.78M$20.11M6.32%+$8.32M
EyePoint, Inc.(EYPT)1,050,0001,050,0000$14.95M$19.18M6.03%+$4.23M
MapLight Therapeutics, Inc.(MPLT)0950,011+950,011$0$16.69M5.25%+$16.69M
Centessa Pharmaceuticals PlcADS680,945580,945-100,000$16.51M$14.53M4.57%-$1.98M
Celldex Therapeutics, Inc.(CLDX)497,270497,2700$12.86M$13.51M4.25%+$641.5K
Tectonic Therapeutic, Inc.(TECX)511,660606,660+95,000$8.03M$12.65M3.98%+$4.63M
Enliven Therapeutics Inc772,477772,4770$15.81M$11.90M3.74%-$3.92M
Artiva Biotherapeutics, Inc.(ARTV)2,353,3042,353,3040$6.75M$10.10M3.17%+$3.34M
Surrozen, Inc.(SRZN)310,000387,500+77,500$3.99M$8.76M2.75%+$4.76M
Biohaven Ltd.(BHVN)478,972738,972+260,000$7.19M$8.34M2.62%+$1.15M
Protara Therapeutics, Inc.(TARA)800,0001,369,782+569,782$3.48M$7.30M2.30%+$3.82M
GH Research PLC(GHRS)572,665572,6650$8.19M$7.27M2.29%-$916.3K
Skye Bioscience, Inc.(SKYE)9,681,7639,681,7630$38.05M$7.26M2.28%-$30.79M
Zentalis Pharmaceuticals, Inc.(ZNTL)490,0003,947,913+3,457,913$739.9K$5.33M1.68%+$4.59M
Silence Therapeutics plcADS(SLN)476,200476,2000$2.47M$2.90M0.91%+$423.8K
Rallybio Corporation(RLYB)3,630,7243,630,7240$1.81M$2.49M0.78%+$679.3K
Adverum Biotechnologies Inc541,6660-541,666$2.45M$0—-$2.45M
Alector Inc995,8410-995,841$2.95M$0—-$2.95M
Dianthus Therapeutics, Inc.(DNTH)365,0530-365,053$14.36M$0—-$14.36M
Mersana Therapeutics Inc52,2000-52,200$405.1K$0—-$405.1K
Praxis Precision Medicines, Inc.(PRAX)170,0000-170,000$9.01M$0—-$9.01M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q4 2025 | TickerTrail